These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10318858)

  • 21. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
    Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
    Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid receptor-interacting protein-1 and receptor-associated coactivator-3 differentially interact with the vitamin D receptor (VDR) and regulate VDR-retinoid X receptor transcriptional cross-talk.
    Issa LL; Leong GM; Barry JB; Sutherland RL; Eisman JA
    Endocrinology; 2001 Apr; 142(4):1606-15. PubMed ID: 11250942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
    Herdick M; Carlberg C
    J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L7 protein is a coregulator of vitamin D receptor-retinoid X receptor-mediated transactivation.
    Berghöfer-Hochheimer Y; Zurek C; Wölfl S; Hemmerich P; Munder T
    J Cell Biochem; 1998 Apr; 69(1):1-12. PubMed ID: 9513041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysine 246 of the vitamin D receptor is crucial for ligand-dependent interaction with coactivators and transcriptional activity.
    Jiménez-Lara AM; Aranda A
    J Biol Chem; 1999 May; 274(19):13503-10. PubMed ID: 10224118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties.
    Lavigne AC; Mengus G; Gangloff YG; Wurtz JM; Davidson I
    Mol Cell Biol; 1999 Aug; 19(8):5486-94. PubMed ID: 10409738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor.
    Liu YY; Collins ED; Norman AW; Peleg S
    J Biol Chem; 1997 Feb; 272(6):3336-45. PubMed ID: 9013574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Malloy PJ; Xu R; Cattani A; Reyes mL; Feldman D
    J Bone Miner Res; 2004 Jun; 19(6):1018-24. PubMed ID: 15190891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric interaction of the 1alpha,25-dihydroxyvitamin D3 receptor and the retinoid X receptor on DNA.
    Kahlen JP; Carlberg C
    Nucleic Acids Res; 1997 Nov; 25(21):4307-13. PubMed ID: 9336462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coactivator-vitamin D receptor interactions mediate inhibition of the atrial natriuretic peptide promoter.
    Chen S; Cui J; Nakamura K; Ribeiro RC; West BL; Gardner DG
    J Biol Chem; 2000 May; 275(20):15039-48. PubMed ID: 10809746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer.
    Chuma M; Endo-Umeda K; Shimba S; Yamada S; Makishima M
    Biol Pharm Bull; 2012; 35(4):582-7. PubMed ID: 22466564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human transcription factor IID subunit human TATA-binding protein-associated factor 28 interacts in a ligand-reversible manner with the vitamin D(3) and thyroid hormone receptors.
    Mengus G; Gangloff YG; Carré L; Lavigne AC; Davidson I
    J Biol Chem; 2000 Apr; 275(14):10064-71. PubMed ID: 10744685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y; Pike JW; Koeffler HP
    Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M; Tanen MR; Bagchi MK
    Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1).
    Castillo AI; Jimenez-Lara AM; Tolon RM; Aranda A
    Mol Endocrinol; 1999 Jul; 13(7):1141-54. PubMed ID: 10406465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription.
    Pike JW; Pathrose P; Barmina O; Chang CY; McDonnell DP; Yamamoto H; Shevde NK
    J Cell Biochem; 2003 Feb; 88(2):252-8. PubMed ID: 12520523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.